EP1478686A1 - A composite, its preparation and use - Google Patents

A composite, its preparation and use

Info

Publication number
EP1478686A1
EP1478686A1 EP02701318A EP02701318A EP1478686A1 EP 1478686 A1 EP1478686 A1 EP 1478686A1 EP 02701318 A EP02701318 A EP 02701318A EP 02701318 A EP02701318 A EP 02701318A EP 1478686 A1 EP1478686 A1 EP 1478686A1
Authority
EP
European Patent Office
Prior art keywords
polymer
composite
process according
water
filler
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02701318A
Other languages
German (de)
French (fr)
Inventor
Oy Bioxid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioxid Oy
Original Assignee
Bioxid Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioxid Oy filed Critical Bioxid Oy
Publication of EP1478686A1 publication Critical patent/EP1478686A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/443—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with carbon fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L31/125—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L31/126—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing carbon fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L31/125—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L31/128—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing other specific inorganic fillers not covered by A61L31/126 or A61L31/127
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L31/125—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L31/129—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/146—Porous materials, e.g. foams or sponges
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
    • C08J7/04—Coating
    • C08J7/043—Improving the adhesiveness of the coatings per se, e.g. forming primers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/36—After-treatment
    • C08J9/40—Impregnation
    • C08J9/405—Impregnation with polymerisable compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2201/00—Foams characterised by the foaming process
    • C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
    • C08J2201/054—Precipitating the polymer by adding a non-solvent or a different solvent
    • C08J2201/0542—Precipitating the polymer by adding a non-solvent or a different solvent from an organic solvent-based polymer composition
    • C08J2201/0544—Precipitating the polymer by adding a non-solvent or a different solvent from an organic solvent-based polymer composition the non-solvent being aqueous
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
    • C08J2333/04—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters
    • C08J2333/06—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters of esters containing only carbon, hydrogen, and oxygen, the oxygen atom being present only as part of the carboxyl radical
    • C08J2333/10—Homopolymers or copolymers of methacrylic acid esters
    • C08J2333/12—Homopolymers or copolymers of methyl methacrylate

Definitions

  • the present invention relates to a process for producing a composite, the composite obtained by said process and the use of said composite.
  • porous biomaterials in applications such as bone augmentation and bone implants is based on the phenomenon that bone can grow into the porous structure of the biomaterial if the pore size of the material varies between 100 to 400 ⁇ m.
  • Several techniques have been used to produce porous polymers. Such techniques are described for example in US patent 4,076,656, where polymer particles are dispersed in water-soluble liquid to form a network of channels in a polymer. A similar technique is also shown in US patent 4,954,381 involving combination of water-soluble polymer and an organic solvent soluble polymer.
  • Document US 4,834,747 presents a method of producing a device having a porous surface by preparing a polymer solution, by coating the device with the solution and by evaporating the solvent.
  • Document US 5,238,636 discloses a similar method for producing porous films and document US 4,384,047 a similar method for producing porous membranes.
  • the porous material obtained by these techniques is however quite weak and soft. The applicants are not aware of any materials having a porous yet stronger structure and being suitable for medical use.
  • An object of the present invention is to provide a composite based on a porous structure but being stronger than the prior art structures and at the same time preferably being suitable for medical use.
  • Another object of the invention is to provide a process for preparing such a composite.
  • a yet further object of the invention is the use of such a composite in different medical applications.
  • the invention relates to a process for producing a polymer composite comprising the steps of
  • step b) mixing water optionally containing a reinforcing filler onto the solution obtained in step a) thus forming an emulsion between the dissolved polymer and the reinforcing filler thereof and the solvent- water solution,
  • reinforcing fillers are present either in step a) or in step b).
  • the invention further relates to a composite obtainable by the inventive process as well to its use in biomaterial applications, structural engineering material applications, dental or orthopedic implants, coatings of fiber reinforced composite implants, as bone augmentation material and bone fixation material, as tissue guiding material, as tissue and cell culturing material, as a drug releasing vehicle material, as absorbing substrate material and/or as construction material.
  • Figure 1 shows a scanning electron microscope (SEM) micrograph of a porous polymethyl methacrylate (PMMA) specimen at lOOOx magnification showing a honeycomb-like structure.
  • Figure 2 shows a SEM micrograph of a porous PMMA having macroscopic (400- 100 ⁇ m) void structure on the surface and a micro porous PMMA structure as shown in Fig. 1.
  • Figure 3 shows a stiff fiber-reinforced composite PMMA core having scale porous PMMA surface.
  • Figure 4 shows a SEM micrograph of a porous PMMA film having a thickness of approximately 150 ⁇ m.
  • Figure 5 shows a SEM micrograph of a fiber-reinforced porous PMMA material.
  • Figure 6 shows a SEM micrograph of a fiber-reinforced porous PMMA material after coating the porous polymer with dimethacrylate monomer.
  • Figure 7 shows a solid fiber-reinforced composite device having a porous surface according to the invention.
  • polymerizing in this application it is meant both polymerizing and crosslinking.
  • dendrimers large spherical hyper-branched polymers are meant.
  • the invention relates to a process for producing a polymer composite comprising the steps of
  • step b) mixing water optionally containing a reinforcing filler onto the solution obtained in step a) thus forming an emulsion between the dissolved polymer and the reinforcing filler thereof and the solvent- water solution,
  • reinforcing fillers are present either in step a) or in step b).
  • a water-insoluble polymer and a reinforcing filler thereof is dissolved into a water-soluble solvent. After this water is mixed with the formed solution of solvent and dissolved polymer and reinforcing filler thereof. As the solvent itself is water-soluble it will mix with the water and the solvent and water will form a homogenous mixture. The polymer and reinforcing filler thereof are water-insoluble, so they will solidify when they come into contact with water. As the solvent evaporates, a highly porous polymer structure is formed. After drying, the porous polymer is ready for the next step of the process, i.e. covering the polymer with a monomer system and polymerizing said monomer system.
  • the present composite is based on a porous structure but yet it is stronger than the prior art structures since it has been reinforced with filler(s).
  • Attempts have previously been made to reinforce and to harden a composite by incorporating reinforcing fibers or particles.
  • the problem encountered in these attempts has however been the poor adhesion of the fibers or particles to the porous material, whereas in the invention, the fillers adhere well to the surrounding material due to the additional coating performed by covering the porous reinforced polymer with a reactive monomer and by further polymerizing it.
  • the materials (polymer, filler, solvent and monomer) used in the process are biocompatible. It is also obvious to a person skilled in the art that the materials are compatible with each other.
  • the materials of the composite may also be resorpables or not and furthermore, they may be bioresorpables and/or biodegradables or not.
  • said filler is present only in the water soluble solvent of step a). According to a yet further embodiment of the invention, said filler is present only in the water of step b). According to a still further embodiment of the invention, said filler is present both in the water soluble solvent of step a) and in the water of step b).
  • the pore size of the formed polymer is easily controlled by controlling the temperature of the water, which is poured onto the solution of solvent and dissolved polymer and reinforcing filler thereof. Use of warmed water will result in faster evaporation of the solvent from the emulsion and thus a smaller pore size of the polymer structure. Porosity, pore size, void volume and surface structure obtained are functions of the molecular size of the polymer, the solvent, the temperature, the evaporation rate as well as the shape, size and nature of the filler.
  • Suitable polymers used in the method according to the invention are different water- insoluble thermoplastic polymers. They can be selected from the group of polymethyl methacrylate (PMMA), polylactide, polycaprolactone, polyamide, polyurethane, polyethylene, polypropylene, other polyolefins and polyvinyl chloride (PVC).
  • said polymerizable monomer system is a monomer or a mixture of monomers having low viscosity.
  • Suitable monomers are monomethacrylates and dimethacrylates as well as methacrylate functionalized dendrimers or other methacrylated hyperbranched polymers.
  • the monomer may for example be ethylene glycoldimethacrylate (EGDMA) or triethylene glycoldimethacrylate (TEGDMA).
  • EGDMA ethylene glycoldimethacrylate
  • TEGDMA triethylene glycoldimethacrylate
  • the same monomer may also be used in step a) as the solvent.
  • the solvent is selected from the group consisting of tetrahydrofuran (THF), acetone and chloroform.
  • THF tetrahydrofuran
  • acetone acetone
  • chloroform acetone
  • the monomer system used in step d) may also be used in step a) as the solvent.
  • fillers are added into the polymer structure.
  • the addition of fillers is done at the stage of dissolving the polymer, i.e. before solidification of the polymer resulting in a porous composite of the polymer and the filler.
  • Fillers can be in the form of fibers or particulate materials and they can also be bioactive agents, such as bioactive glass.
  • Suitable fibers that can be used as filler in the process according to the invention can be selected from a group consisting of inert glass fibers, bioactive glass fibers, carbon/graphite fibers, aramid fibers, polyethylene fibers, collagen and natural fibers.
  • suitable natural fibers are cellulose and modified cellulose fibers.
  • Particulate material that can be used as filler in the process according to the invention can be selected from a group consisting of inert glass, bioactive glass, silica gel, titanium gel, carbon, graphite, aramid, polyethylene, gypsum and hydroxyapatite, as well as different mixtures of these materials. It is also obvious to a person skilled in the art that the composite may contain both fibrous and particulate filler materials.
  • Different pharmaceutically active agents can be incorporated in the composite produced by the process according to the invention. Such agents can be added for example when a porous composite according to the invention is used in bone augmentation and implant applications.
  • the pharmaceutically active agent can be added to the composite before solidification of the polymer structure, or alternatively, they can be incorporated into the porous structure after the solidification of the porous composite by further impregnation, before the step of coating of the porous polymer. It is obvious that the composite according to the invention may contain one or more of such active agents.
  • pharmaceutically active agents it is meant different drugs, biologically active substances and fherapeutically active substances.
  • the pharmaceutically active agent can be selected for example from the group consisting of bone morphogenic proteins (BMPs), interferons, corticosteroids, biphosphonates, cytostatics, anabolic hormones, vitamins, anti-inflammatory drugs, antimicrobiotics, disinfectants and combinations and mixtures thereof. This is to be taken as a non-limiting list of examples and a person skilled in the art is able to find more examples of suitable active agents.
  • BMPs bone morphogenic proteins
  • interferons corticosteroids
  • biphosphonates cytostatics
  • anabolic hormones vitamins, anti-inflammatory drugs, antimicrobiotics, disinfectants and combinations and mixtures thereof.
  • the pharmaceutically active agents can be released from the porous polymeric structure by diffusion.
  • the porous polymers and composites produced according the invention are extremely suitable as the pore size can be optimized.
  • the pore size of the composites can be optimized so that there is both macro pores and micro pores. Macro pores of size 100-1000 ⁇ m will contribute e.g. bone growth when the material is used as implants. Micro pores, with size in nanometer scale, are important for controlled diffusion of active agents and drugs.
  • the nanometer scale pore size can be obtained by adding fillers containing nanometer size pores into the porous polymer.
  • Such fillers can be made of polymers like dendrimers, or of inorganic material like Si ⁇ 2-
  • a further use of the present inventive process is the coating of an existing device with the composite according to the invention.
  • the inventive process gives an advantageous method for producing materials consisting of several layers, wherein the different layers have a good adhesion to each other.
  • the device to be coated may be any suitable device such as an implant, a fixation nail, a polymer block or a composite and it may be manufactured from any material such as bioactive glass or a polymer, bioactive or not.
  • the thickness of the porous surface layer can be determined by the dissolving time of the solid surface in the solvent.
  • the pore size can also here be modified by the process conditions: water temperature and pressure, used solvent and polymer and molecular size of the polymer as well as the properties of the filler material.
  • a device may be coated in two different ways. Indeed, it may be coated by covering it with a solution of water insoluble polymer and a filler followed by the steps b) to e) of the present process.
  • This second way leads to a coating having a less marked interface between the device and the coating and also improved adhesion of the coating due to the penetration of the materials of the coating to the materials of the device, i.e. increased interdiffusion bonding.
  • the invention further relates to the composite obtainable according to the present process.
  • the composite according to the invention is based on a porous polymer.
  • the pores may be either totally or partially filled with the polymerized monomer of the monomer system of step d).
  • the pores are from 100 to 1000 ⁇ m in size.
  • the invention also relates to the use of the inventive composite.
  • the composite according to the invention can be used in different biological applications (as a biomaterial, for example) or in structural engineering applications. It can be used for example in dental or orthopedic implants, coatings for FRC implants, as bone augmentation material and fixing material, as tissue guiding and cell culturing material or as a drug releasing vehicle material.
  • the composite according to the invention can also be used in the fabrication of porous ceramic device or implant by replica technique.
  • replica technique it is meant that porous polymer structure is copied by ceramic powder which is then sintered at elevated temperature to form a solid ceramic of porous structure.
  • the replica technique allows to production of a ceramic device or implant that has the same porous structure of the polymer, i.e. the porous structure of the polymer is copied to the ceramic material.
  • Said ceramic material may be for example aluminium oxide or the like.
  • the composite according to the invention can also be used in other technical applications such in filters, absorbing substrate or construction material. It will be appreciated that the essence of the present invention can be incorporated in the form of a variety of embodiments, only a few of which are disclosed herein. It will be apparent for the specialist in the field that other embodiments exist and do not depart from the spirit of the invention. Thus, the described embodiments are illustrative and should not be construed as restrictive.
  • Examples la to lc disclose the preparation of micrometer and nanometer scale porous polymer to be used in the preparation of a composite according to the invention.
  • Example 2 discloses the preparation of the porous PMMA having macroscopic scale void structure and example 3 presents the preparation of a fiber reinforced composite (FRC) core having a micrometer scale porous PMMA surface.
  • Example 4 discloses the preparation of a microscopic scale porous PMMA film to be used in a composite according to the invention.
  • Example 5 presents the preparation of porous PMMA containing silica fillers.
  • Example 6 shows the preparation of PMMA containing glass fibers.
  • Examples 7 and 8 disclose the preparation of a composite according to the invention.
  • PMMA polymethyl methacrylate
  • THF tetrahydrofuran
  • PMMA polymethyl methacrylate
  • THF tetrahydrofuran
  • PMMA polymethyl methacrylate
  • PMMA polymethyl methacrylate
  • THF tetrahydrofuran
  • PMMA formed more complex surface structure with macroscopic voids.
  • a PMMA pre-core was manufactured using PalaPress (provided by Heraus Kulzer, Germany) according to the manufacturer's recommendations. Continuous E-glass fiber reinforcement (StickTM by StickTech Oy, Finland) was added into a polymethyl methacrylate/ methyl methacrylate mixture (PMMA/MMA). Stiff FRC- PMMA core was cured in a pressure-curing device at a pressure of 2 bar and temperature of 55 °C (Ivomat®, by Schaan, Liechtenstein). After the FRC-PMMA specimen was cured, it was inserted into THF for 5 hours in order to obtain a PMMA-gel on the surface of the specimen. The specimen was then inserted into warm water (50 °C) and a porous PMMA surface was obtained having a strong FRC-core, as illustrated in Figure 3.
  • PMMA polymethyl methacrylate
  • THF tetrahydrofuran
  • the porous fiber reinforced PMMA obtained in Example 6 was dipped in ethylene glycol dimethacrylate (EGDMA) monomer containing 2 wt-% of benzoylperoxide as an initiator.
  • EGDMA ethylene glycol dimethacrylate
  • the porous PMMA was then polymerized together with EGDMA by heating the material at 70 °C for 2 hours.
  • a reinforced and EGDMA-coated composite was obtained as a result, and illustrated in Figure 6.
  • FIG. 7 shows schematically a composite according to an embodiment of the present invention.
  • the Figure shows the short glass fibers 1, the fiber reinforced composite 3 and the porous layer 2 at the surface of the composite 3.
  • nanometer scale porous silica (Si ⁇ 2) fillers of size 0,5 to 50 ⁇ m containing biphosphonate were mixed to the THF-PMMA-gel.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Composite Materials (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

The invention relates to a process for producing a polymer composite comprising the steps of a) dissolving a water insoluble polymer and optionally a reinforcing filler thereof into a water soluble solvent, b) mixing water optionally containing a reinforcing filler onto the solution obtained in step a) thus forming an emulsion between the dissolved polymer and the reinforcing filler thereof and the solvent-water solution, c) allowing said solvent to evaporate simultaneously with the solidification of the polymer thus creating a porous reinforced polymer, d) covering said porous reinforced polymer with a polymerizable monomer system, and e) polymerizing said monomer system thus creating a polymer composite, provided that reinforcing fillers are present either in step a) or in step b). The invention further relates to the composite obtainable by the process and the use thereof.

Description

A COMPOSITE, ITS PREPARATION AND USE
FIELD OF THE INVENTION
The present invention relates to a process for producing a composite, the composite obtained by said process and the use of said composite.
BACKGROUND OF THE INVENTION
The use of porous biomaterials in applications such as bone augmentation and bone implants is based on the phenomenon that bone can grow into the porous structure of the biomaterial if the pore size of the material varies between 100 to 400 μm. Several techniques have been used to produce porous polymers. Such techniques are described for example in US patent 4,076,656, where polymer particles are dispersed in water-soluble liquid to form a network of channels in a polymer. A similar technique is also shown in US patent 4,954,381 involving combination of water-soluble polymer and an organic solvent soluble polymer.
Document US 4,834,747 presents a method of producing a device having a porous surface by preparing a polymer solution, by coating the device with the solution and by evaporating the solvent. Document US 5,238,636 discloses a similar method for producing porous films and document US 4,384,047 a similar method for producing porous membranes. The porous material obtained by these techniques is however quite weak and soft. The applicants are not aware of any materials having a porous yet stronger structure and being suitable for medical use.
OBJECT OF THE INVENTION
An object of the present invention is to provide a composite based on a porous structure but being stronger than the prior art structures and at the same time preferably being suitable for medical use.
Another object of the invention is to provide a process for preparing such a composite. A yet further object of the invention is the use of such a composite in different medical applications. SUMMARY OF THE INVENTION
The invention relates to a process for producing a polymer composite comprising the steps of
a) dissolving a water insoluble polymer and optionally a reinforcing filler thereof into a water soluble solvent,
b) mixing water optionally containing a reinforcing filler onto the solution obtained in step a) thus forming an emulsion between the dissolved polymer and the reinforcing filler thereof and the solvent- water solution,
c) allowing said solvent to evaporate simultaneously with the solidification of the polymer thus creating a porous reinforced polymer,
d) covering said porous reinforced polymer with a polymerizable monomer system, and
e) polymerizing said monomer system thus creating a polymer composite,
provided that reinforcing fillers are present either in step a) or in step b).
The invention further relates to a composite obtainable by the inventive process as well to its use in biomaterial applications, structural engineering material applications, dental or orthopedic implants, coatings of fiber reinforced composite implants, as bone augmentation material and bone fixation material, as tissue guiding material, as tissue and cell culturing material, as a drug releasing vehicle material, as absorbing substrate material and/or as construction material.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 shows a scanning electron microscope (SEM) micrograph of a porous polymethyl methacrylate (PMMA) specimen at lOOOx magnification showing a honeycomb-like structure.
Figure 2 shows a SEM micrograph of a porous PMMA having macroscopic (400- 100 μm) void structure on the surface and a micro porous PMMA structure as shown in Fig. 1.
Figure 3 shows a stiff fiber-reinforced composite PMMA core having scale porous PMMA surface. Figure 4 shows a SEM micrograph of a porous PMMA film having a thickness of approximately 150 μm.
Figure 5 shows a SEM micrograph of a fiber-reinforced porous PMMA material.
Figure 6 shows a SEM micrograph of a fiber-reinforced porous PMMA material after coating the porous polymer with dimethacrylate monomer.
Figure 7 shows a solid fiber-reinforced composite device having a porous surface according to the invention.
DETAILED DESCRIPTION OF THE INVENTION
By "polymerizing" in this application it is meant both polymerizing and crosslinking.
Furthermore, by dendrimers large spherical hyper-branched polymers are meant.
The invention is characterized by the enclosed claims.
The invention relates to a process for producing a polymer composite comprising the steps of
a) dissolving a water insoluble polymer and optionally a reinforcing filler thereof into a water soluble solvent,
b) mixing water optionally containing a reinforcing filler onto the solution obtained in step a) thus forming an emulsion between the dissolved polymer and the reinforcing filler thereof and the solvent- water solution,
c) allowing said solvent to evaporate simultaneously with the solidification of the polymer thus creating a porous reinforced polymer,
d) covering said porous reinforced polymer with a polymerizable monomer system, and
e) polymerizing said monomer system thus creating a polymer composite,
provided that reinforcing fillers are present either in step a) or in step b).
In the process according to the invention a water-insoluble polymer and a reinforcing filler thereof is dissolved into a water-soluble solvent. After this water is mixed with the formed solution of solvent and dissolved polymer and reinforcing filler thereof. As the solvent itself is water-soluble it will mix with the water and the solvent and water will form a homogenous mixture. The polymer and reinforcing filler thereof are water-insoluble, so they will solidify when they come into contact with water. As the solvent evaporates, a highly porous polymer structure is formed. After drying, the porous polymer is ready for the next step of the process, i.e. covering the polymer with a monomer system and polymerizing said monomer system.
The objects of the invention are thus fulfilled with the inventive process and composite. Indeed, the present composite is based on a porous structure but yet it is stronger than the prior art structures since it has been reinforced with filler(s). Attempts have previously been made to reinforce and to harden a composite by incorporating reinforcing fibers or particles. The problem encountered in these attempts has however been the poor adhesion of the fibers or particles to the porous material, whereas in the invention, the fillers adhere well to the surrounding material due to the additional coating performed by covering the porous reinforced polymer with a reactive monomer and by further polymerizing it.
According to an embodiment of the invention, the materials (polymer, filler, solvent and monomer) used in the process are biocompatible. It is also obvious to a person skilled in the art that the materials are compatible with each other. The materials of the composite may also be resorpables or not and furthermore, they may be bioresorpables and/or biodegradables or not.
According to a further embodiment of the invention, said filler is present only in the water soluble solvent of step a). According to a yet further embodiment of the invention, said filler is present only in the water of step b). According to a still further embodiment of the invention, said filler is present both in the water soluble solvent of step a) and in the water of step b).
Using the process according to the invention the pore size of the formed polymer is easily controlled by controlling the temperature of the water, which is poured onto the solution of solvent and dissolved polymer and reinforcing filler thereof. Use of warmed water will result in faster evaporation of the solvent from the emulsion and thus a smaller pore size of the polymer structure. Porosity, pore size, void volume and surface structure obtained are functions of the molecular size of the polymer, the solvent, the temperature, the evaporation rate as well as the shape, size and nature of the filler. Suitable polymers used in the method according to the invention are different water- insoluble thermoplastic polymers. They can be selected from the group of polymethyl methacrylate (PMMA), polylactide, polycaprolactone, polyamide, polyurethane, polyethylene, polypropylene, other polyolefins and polyvinyl chloride (PVC).
According to an embodiment of the invention, said polymerizable monomer system is a monomer or a mixture of monomers having low viscosity. Suitable monomers are monomethacrylates and dimethacrylates as well as methacrylate functionalized dendrimers or other methacrylated hyperbranched polymers. The monomer may for example be ethylene glycoldimethacrylate (EGDMA) or triethylene glycoldimethacrylate (TEGDMA). The same monomer may also be used in step a) as the solvent.
According to another embodiment of the invention, the solvent is selected from the group consisting of tetrahydrofuran (THF), acetone and chloroform. The monomer system used in step d) may also be used in step a) as the solvent.
In the process according to the invention different fillers are added into the polymer structure. The addition of fillers is done at the stage of dissolving the polymer, i.e. before solidification of the polymer resulting in a porous composite of the polymer and the filler. Fillers can be in the form of fibers or particulate materials and they can also be bioactive agents, such as bioactive glass.
Suitable fibers that can be used as filler in the process according to the invention can be selected from a group consisting of inert glass fibers, bioactive glass fibers, carbon/graphite fibers, aramid fibers, polyethylene fibers, collagen and natural fibers. Examples of suitable natural fibers are cellulose and modified cellulose fibers.
Particulate material that can be used as filler in the process according to the invention can be selected from a group consisting of inert glass, bioactive glass, silica gel, titanium gel, carbon, graphite, aramid, polyethylene, gypsum and hydroxyapatite, as well as different mixtures of these materials. It is also obvious to a person skilled in the art that the composite may contain both fibrous and particulate filler materials.
Different pharmaceutically active agents can be incorporated in the composite produced by the process according to the invention. Such agents can be added for example when a porous composite according to the invention is used in bone augmentation and implant applications. The pharmaceutically active agent can be added to the composite before solidification of the polymer structure, or alternatively, they can be incorporated into the porous structure after the solidification of the porous composite by further impregnation, before the step of coating of the porous polymer. It is obvious that the composite according to the invention may contain one or more of such active agents.
By pharmaceutically active agents it is meant different drugs, biologically active substances and fherapeutically active substances. The pharmaceutically active agent can be selected for example from the group consisting of bone morphogenic proteins (BMPs), interferons, corticosteroids, biphosphonates, cytostatics, anabolic hormones, vitamins, anti-inflammatory drugs, antimicrobiotics, disinfectants and combinations and mixtures thereof. This is to be taken as a non-limiting list of examples and a person skilled in the art is able to find more examples of suitable active agents.
The pharmaceutically active agents can be released from the porous polymeric structure by diffusion. As the pore size is an important variable in control of the diffusion, the porous polymers and composites produced according the invention are extremely suitable as the pore size can be optimized. The pore size of the composites can be optimized so that there is both macro pores and micro pores. Macro pores of size 100-1000 μm will contribute e.g. bone growth when the material is used as implants. Micro pores, with size in nanometer scale, are important for controlled diffusion of active agents and drugs. Optionally the nanometer scale pore size can be obtained by adding fillers containing nanometer size pores into the porous polymer. Such fillers can be made of polymers like dendrimers, or of inorganic material like Siθ2-
A further use of the present inventive process is the coating of an existing device with the composite according to the invention. Indeed, the inventive process gives an advantageous method for producing materials consisting of several layers, wherein the different layers have a good adhesion to each other. The device to be coated may be any suitable device such as an implant, a fixation nail, a polymer block or a composite and it may be manufactured from any material such as bioactive glass or a polymer, bioactive or not.
The thickness of the porous surface layer can be determined by the dissolving time of the solid surface in the solvent. The pore size can also here be modified by the process conditions: water temperature and pressure, used solvent and polymer and molecular size of the polymer as well as the properties of the filler material.
A device may be coated in two different ways. Indeed, it may be coated by covering it with a solution of water insoluble polymer and a filler followed by the steps b) to e) of the present process. This leads to a coating having a more marked interface between the device and the coating than the second inventive way, which consists on dissolving the surface of the device consisting of a polymer or reinforced polymer followed by the treatment of the partly diluted surface with water and further the steps c) to e) of the present process. This second way leads to a coating having a less marked interface between the device and the coating and also improved adhesion of the coating due to the penetration of the materials of the coating to the materials of the device, i.e. increased interdiffusion bonding.
The invention further relates to the composite obtainable according to the present process. The composite according to the invention is based on a porous polymer. In the finished composite, the pores may be either totally or partially filled with the polymerized monomer of the monomer system of step d). Preferably, the pores are from 100 to 1000 μm in size.
The invention also relates to the use of the inventive composite. Indeed, the composite according to the invention can be used in different biological applications (as a biomaterial, for example) or in structural engineering applications. It can be used for example in dental or orthopedic implants, coatings for FRC implants, as bone augmentation material and fixing material, as tissue guiding and cell culturing material or as a drug releasing vehicle material.
The composite according to the invention can also be used in the fabrication of porous ceramic device or implant by replica technique. By replica technique it is meant that porous polymer structure is copied by ceramic powder which is then sintered at elevated temperature to form a solid ceramic of porous structure. In this embodiment, the replica technique allows to production of a ceramic device or implant that has the same porous structure of the polymer, i.e. the porous structure of the polymer is copied to the ceramic material. Said ceramic material may be for example aluminium oxide or the like.
The composite according to the invention can also be used in other technical applications such in filters, absorbing substrate or construction material. It will be appreciated that the essence of the present invention can be incorporated in the form of a variety of embodiments, only a few of which are disclosed herein. It will be apparent for the specialist in the field that other embodiments exist and do not depart from the spirit of the invention. Thus, the described embodiments are illustrative and should not be construed as restrictive.
EXPERIMENTAL PART
Examples la to lc disclose the preparation of micrometer and nanometer scale porous polymer to be used in the preparation of a composite according to the invention. Example 2 discloses the preparation of the porous PMMA having macroscopic scale void structure and example 3 presents the preparation of a fiber reinforced composite (FRC) core having a micrometer scale porous PMMA surface. Example 4 discloses the preparation of a microscopic scale porous PMMA film to be used in a composite according to the invention. Example 5 presents the preparation of porous PMMA containing silica fillers. Example 6 shows the preparation of PMMA containing glass fibers. Examples 7 and 8 disclose the preparation of a composite according to the invention.
Example la
2.00 g of polymethyl methacrylate (PMMA) was dissolved in 5 ml of tetrahydrofuran (THF). After the PMMA gel was formed, 0.2 g of glass fiber wool was added into the mixture. Warmed (50 °C) water was poured onto the obtained mixture causing PMMA to coagulate. Channels were formed in the polymer structure by evaporation of the THF, as illustrated in Figure 1. A porosity/void percentage of 51 vol-% was achieved.
Example lb
2.00 g of polymethyl methacrylate (PMMA) was dissolved in 5 ml of tetrahydrofuran (THF). After the PMMA gel was formed, 0.2 g of glass fiber wool was added into the mixture. Boiling water (100 °C) was poured onto the obtained mixture causing PMMA to coagulate. Channels were formed in the polymer structure by evaporation of the THF. A porosity/void percentage of 72 vol-% was achieved. Example lc
2.00 g of polymethyl methacrylate (PMMA) was dissolved in 5 ml of acetone. After the PMMA gel was formed, 0.4 g of glass fiber wool was added into mixture. Boiling water (100 °C) was poured onto the obtained mixture causing PMMA to solidify. Channels were formed in the polymer structure by evaporation of the acetone. A porosity/void percentage of 81 vol-% was achieved.
Example 2
2.0 g of polymethyl methacrylate (PMMA) was dissolved in 5 ml of tetrahydrofuran (THF). After the PMMA gel was formed, cold water (8 °C) was poured onto the obtained mixture causing PMMA to solidify slowly. Micro pores and macro voids were formed slowly during the first 24 hours by evaporation of the THF, as shown in Figure 2.
When low water temperature was used, PMMA formed more complex surface structure with macroscopic voids.
Example 3
A PMMA pre-core was manufactured using PalaPress (provided by Heraus Kulzer, Germany) according to the manufacturer's recommendations. Continuous E-glass fiber reinforcement (Stick™ by StickTech Oy, Finland) was added into a polymethyl methacrylate/ methyl methacrylate mixture (PMMA/MMA). Stiff FRC- PMMA core was cured in a pressure-curing device at a pressure of 2 bar and temperature of 55 °C (Ivomat®, by Schaan, Liechtenstein). After the FRC-PMMA specimen was cured, it was inserted into THF for 5 hours in order to obtain a PMMA-gel on the surface of the specimen. The specimen was then inserted into warm water (50 °C) and a porous PMMA surface was obtained having a strong FRC-core, as illustrated in Figure 3.
Example 4
2.0 g of polymethyl methacrylate (PMMA) was dissolved in 5 ml of tetrahydrofuran (THF). After the PMMA gel was formed, it was inserted into a syringe. The gel was injected onto a glass plate so that a film was formed. Warm water (50 °C) was poured onto the mixture causing PMMA to solidify. Evaporation channels were formed by the evaporation of the THF and porous PMMA film was obtained. Alternatively the PMMA gel was injected onto warm water so that a thin PMMA film is formed onto the water surface, as presented in Figure 4.
Example 5
7,0 g of polymethyl methacrylate (Palapress Clear, PMMA-fillers) was dissolved in 100 ml of tetrahydrofuran (THF). 100 ml of water, 20 ml of tetraefhylene orthosilane (TEOS), 100 ml of ethanol and 2 ml of 1.0 M HC1 were mixed in order to prepare a sol-gel silica. After 24 hours, water containing said sol-gel silica was poured into PMMA/THF causing porous PMMA having silica partiles to be formed. The porous specimen was then dipped to EGDMA containing 2 wt-% of benzoyl peroxide (BPO) and polymerized.
Example 6
50 ml of PMMA was dissolved in 120 ml of THF. 20 ml of short glass fibers ( E- glass, length 2 mm) were mixed into the PMMA/THF-gel. The obtained mixture was poured into warm water and a fiber reinforced porous PMMA was obtained, as illustrated in Figure 5.
Example 7
The porous fiber reinforced PMMA obtained in Example 6 was dipped in ethylene glycol dimethacrylate (EGDMA) monomer containing 2 wt-% of benzoylperoxide as an initiator. The porous PMMA was then polymerized together with EGDMA by heating the material at 70 °C for 2 hours. A reinforced and EGDMA-coated composite was obtained as a result, and illustrated in Figure 6.
Example 8
A glass fiber reinforced composite prepared according to known methods and having a linear PMMA matrix was inserted to a mixture of THF and PMMA for one (1) minute. Short glass fibers as the filler component of a porous surface were mixed to the THF-PMMA-gel. Water was poured into the THF-PMMA-gel with fiber material. A solid material having a porous surface layer with interdiffusion bonding was obtained. The porous surface layer containing the short glass fibers was coated with EGDMA monomer containing 2 wt-% of benzoylperoxide as an initiator and polymerized heating the material at 70 °C for 2 hours. Furthermore, Figure 7 shows schematically a composite according to an embodiment of the present invention. The Figure shows the short glass fibers 1, the fiber reinforced composite 3 and the porous layer 2 at the surface of the composite 3.
Example 9
The example 8 was repeated except that instead of the glass fibers, nanometer scale porous silica (Siθ2) fillers of size 0,5 to 50 μm containing biphosphonate were mixed to the THF-PMMA-gel.

Claims

Claims
1. A process for producing a polymer composite comprising the steps of
a) dissolving a water insoluble polymer and optionally a reinforcing filler thereof into a water soluble solvent,
b) mixing water optionally containing a reinforcing filler onto the solution obtained in step a) thus forming an emulsion between the dissolved polymer and the reinforcing filler thereof and the solvent-water solution,
c) allowing said solvent to evaporate simultaneously with the solidification of the polymer thus creating a porous reinforced polymer,
d) covering said porous reinforced polymer with a polymerizable monomer system, and
e) polymerizing said monomer system thus creating a polymer composite,
provided that reinforcing fillers are present either in step a) or in step b).
2. The process according to claim 1, characterized in that said polymer is selected from the group consisting of polymethyl methacrylate, polylactide, polycaprolactone, polyamide, polyethylene, polypropylene, polyurethane and polyvinyl chloride.
3. The process according to claim 1 or 2, characterized in that said solvent is selected from the group consisting of tetrahydrofuran, acetone, chloroform and mixtures thereof.
4. The process according to any of the preceding claims, characterized in that said polymerizable monomer system is selected from the group consisting of monomethacrylate, dimethacrylate, methacrylate functionalized dendrimers and mixtures thereof.
5. The process according to any of the preceding claims, characterized in that said filler is present only in the water soluble solvent of step a).
6. The process according to any of the claims 1 to 4, characterized in that said filler is present only in the water of step b).
7. The process according to any of the claims 1 to 4, characterized in that said filler is present both in the water soluble solvent of step a) and in the water of step b).
8. The process according to any of the preceding claims, characterized in that said filler is a fiber or a particulate material.
9. The process according to claim 8, characterized in that said filler is a fiber and is selected from the group consisting of inert glass fibers, bioactive glass fibers, carbon/graphite fibers, aramid fibers, polyethylene fibers, collagen, natural fibers and mixtures thereof.
10. The process according to claim 8, characterized in that said filler is a particulate material, the material being selected from the group consisting of inert glass, bioactive glass, silica gel, titanium gel, carbon, graphite, aramid, polyethylene, gypsum, hydroxyapatite, silicium oxide and mixtures thereof.
11. The process according to any of the preceding claims, characterized in that a pharmaceutically active agent has been added before or after solidification of the polymer.
12. The process according to claim 11, characterized in that said pharmaceutically active agent is selected from the group consisting of bone morphogenetic proteins, interferons, corticosteroids, biphosphonates, cytostatics, anabolic hormones, vitamins, anti-inflammatory drugs, antimicrobial agents, disinfectants and mixtures thereof.
13. A composite obtainable by the process according to any of claims 1 to 12.
14. The composite according to claim 13, characterized in that it is biocompatible.
15. Use of the composite according to claim 14 in biomaterial applications or in structural engineering material applications.
16. Use of the composite according to claim 14 in dental or orthopedic implants, coatings of fiber reinforced composite implants, as bone augmentation material and bone fixation material, as tissue guiding material, as tissue and cell culturing material or as a drug releasing vehicle material.
17. Use of the composite according to claim 13 or 14 in the fabrication of porous ceramic device or implant by replica technique.
18. Use of the composite according to claim 13 or 14 in filters, as absorbing substrate material or as construction material.
EP02701318A 2001-02-28 2002-02-28 A composite, its preparation and use Withdrawn EP1478686A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20010403A FI20010403A0 (en) 2001-02-28 2001-02-28 Porous polymer and composite
FI20010403 2001-02-28
PCT/FI2002/000158 WO2002068517A1 (en) 2001-02-28 2002-02-28 A composite, its preparation and use

Publications (1)

Publication Number Publication Date
EP1478686A1 true EP1478686A1 (en) 2004-11-24

Family

ID=8560570

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02701318A Withdrawn EP1478686A1 (en) 2001-02-28 2002-02-28 A composite, its preparation and use

Country Status (3)

Country Link
EP (1) EP1478686A1 (en)
FI (1) FI20010403A0 (en)
WO (1) WO2002068517A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113214587A (en) * 2021-06-01 2021-08-06 浙江华帅特新材料科技有限公司 Transparent, antibacterial organic glass and its manufacturing method

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104548199B (en) * 2015-01-14 2016-08-17 石家庄铁道大学 A kind of biological hard tissue substitutes and repair materials and preparation method thereof
EP3153230A1 (en) 2015-10-08 2017-04-12 The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of Holy and Undiv. Trinity of Queen Elizabeth near Dublin A method for the production of poly(methyl methacrylate) (pmma) membranes and uses thereof
CN105924604B (en) * 2016-05-18 2018-09-25 湖南科技大学 A kind of preparation method and product of degradable aqueous polyurethane coating
CN114479449A (en) * 2022-03-16 2022-05-13 山东交通学院 Composite material for ground restoration and bearing reinforcement engineering, preparation method and application
CN116640354B (en) * 2023-05-29 2024-06-21 武汉纺织大学 Polyurethane-Kevlar composite porous film and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384047A (en) * 1980-03-28 1983-05-17 Pennwalt Corporation Porous vinylidene fluoride polymer membrane and process for its preparation
US5290494A (en) * 1990-03-05 1994-03-01 Board Of Regents, The University Of Texas System Process of making a resorbable implantation device
US5217802A (en) * 1992-03-17 1993-06-08 Millipore Corporation Hydrophobic polymeric membrane composites
DE4229477A1 (en) * 1992-09-03 1994-03-10 Miles Inc Prepn. of a highly porous membrane - by selective removal of polymers; useful as testing strips in urine analysis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO02068517A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113214587A (en) * 2021-06-01 2021-08-06 浙江华帅特新材料科技有限公司 Transparent, antibacterial organic glass and its manufacturing method

Also Published As

Publication number Publication date
WO2002068517A1 (en) 2002-09-06
FI20010403A0 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
Babaie et al. Fabrication aspects of porous biomaterials in orthopedic applications: A review
EP2173792B1 (en) Multi-polymer hydrogels
EP3003415B1 (en) Implant with controlled porosity comprising a matrix covered by a bioactive glass or by a hybrid material
EP1377325A1 (en) Composite for attaching, growing and/or repairing of living tissues and use of said composite
US20130261212A1 (en) Polyurethane-grafted hydrogels
US20070036844A1 (en) Porous materials having multi-size geometries
WO2005020849A2 (en) Hydrogel porogens for fabricating biodegradable scaffolds
US7943677B2 (en) Method of producing interconnected volumetric porosity in materials
WO2002068517A1 (en) A composite, its preparation and use
EP3634304B1 (en) An implantable medical device
JP2012016517A (en) Bone regeneration material and method for manufacturing the same
Puska et al. Improvement of mechanical properties of oligomer-modified acrylic bone cement with glass-fibers
US7332113B2 (en) Method for the production of a biocompatible polymer-ceramic composite material with a predetermined porosity
Ronca et al. Polymer based scaffolds for tissue regeneration by stereolithography
Naseri et al. Bioactive Glass Particulate-incorporated Polymer Composites
CN117106175A (en) Method for preparing poly-L-benzyl glutamate based nanofiber bone scaffold by 3D printing one-step method
Reza Rezaie et al. Conductivity: Materials Design
Netti et al. Engineering novel scaffolds with in silico designed microarchitectures and potentially suitable for spatio-temporal drugs release

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030929

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061201